| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Puma Biotechnology, Inc.'s insiders have reduced their positions by a net 44,058 shares worth roughly $364K.
PBYI sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 7.26M | $64.70M | - | |
| CFO | 240.0K | $2.14M | - | |
| Other | 205.3K | $1.83M | - | |
| Dir | 54.0K | $481.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 2, 2020 | Bryce Richard Paul | See Remarks | Sell | 91 | $7.37 | $670.68 | -0.1% | |
| Apr 2, 2020 | Auerbach Alan H62 | President And CEO | Sell | 347 | $7.39 | $2,562.60 | - | |
| Mar 2, 2020 | Bryce Richard Paul | See Remarks | Sell | 96 | $10.02 | $962.15 | -0.1% | |
| Mar 2, 2020 | Auerbach Alan H62 | President And CEO | Sell | 372 | $10.02 | $3,725.62 | - | |
| Feb 27, 2020 | Hunt Douglas M62 | See Remarks | Sell | 1,728 | $10.25 | $17,717.18 | -3.2% | |
| Feb 3, 2020 | Bryce Richard Paul | See Remarks | Sell | 105 | $8.02 | $841.58 | -0.3% | |
| Feb 3, 2020 | Auerbach Alan H62 | President And CEO | Sell | 331 | $8.01 | $2,652.80 | - | |
| Jan 2, 2020 | Hunt Douglas M62 | See Remarks | Sell | 1,405 | $8.43 | $11,846.96 | -11.1% | |
| Jan 2, 2020 | Auerbach Alan H62 | President And CEO | Sell | 6,016 | $8.39 | $50,471.23 | - | |
| Jan 2, 2020 | Bryce Richard Paul | See Remarks | Sell | 1,516 | $8.40 | $12,734.32 | -2.1% |